Pediatrix Medical
0
Funds holding %
of 7,398 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
2,161% more call options, than puts
Call options by funds: $701K | Put options by funds: $31K
67% more first-time investments, than exits
New positions opened: 35 | Existing positions closed: 21
7% more capital invested
Capital invested by funds: $1.01B [Q3] → $1.08B (+$73.8M) [Q4]
5% more funds holding
Funds holding: 216 [Q3] → 227 (+11) [Q4]
8% more repeat investments, than reductions
Existing positions increased: 79 | Existing positions reduced: 73
5.36% less ownership
Funds ownership: 101.14% [Q3] → 95.78% (-5.36%) [Q4]
50% less funds holding in top 10
Funds holding in top 10: 2 [Q3] → 1 (-1) [Q4]
Research analyst outlook
2 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$18
25%
upside
Avg. target
$18.25
26%
upside
High target
$18.50
28%
upside
2 analyst ratings
0 positive
0%
2 neutral
100%
0 negative
0%
UBS A.J. Rice 41% 1-year accuracy 7 / 17 met price target | 28%upside $18.50 | Neutral Maintained | 21 Feb 2025 |
Truist Securities David Macdonald 62% 1-year accuracy 58 / 93 met price target | 25%upside $18 | Hold Maintained | 21 Feb 2025 |
Financial journalist opinion
Based on 8 articles about MD published over the past 30 days
Positive
Zacks Investment Research
4 hours ago
5 Relative Price Strength Stocks to Navigate Today's Market
IHS, ANIP, MD, FMS and TREE are five stocks with explosive relative price strength.
Positive
Zacks Investment Research
5 days ago
3 Medical Services Industry Stocks to Buy as AI Fuels Growth
The Zacks Medical - Services industry is undergoing a transformation on massive artificial intelligence adoption. COR, DOCS and MD are set to gain the most.
Positive
Zacks Investment Research
1 week ago
Wall Street Analysts Think Pediatrix Medical Group (MD) Could Surge 27.97%: Read This Before Placing a Bet
The consensus price target hints at a 28% upside potential for Pediatrix Medical Group (MD). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Positive
Zacks Investment Research
2 weeks ago
Fast-paced Momentum Stock Pediatrix Medical Group (MD) Is Still Trading at a Bargain
Pediatrix Medical Group (MD) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
Positive
Zacks Investment Research
2 weeks ago
MD vs. HQY: Which Stock Should Value Investors Buy Now?
Investors with an interest in Medical Services stocks have likely encountered both Pediatrix Medical Group (MD) and HealthEquity (HQY). But which of these two stocks is more attractive to value investors?
Positive
Zacks Investment Research
3 weeks ago
Why Pediatrix Medical Group (MD) is a Top Momentum Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Positive
Zacks Investment Research
3 weeks ago
Pediatrix Medical Stock Rallies 37.7% in 6 Months: More Room to Run?
MD is expected to benefit from rising patient volumes, a favorable payer mix and streamlining initiatives.
Positive
Zacks Investment Research
4 weeks ago
Wall Street Analysts Believe Pediatrix Medical Group (MD) Could Rally 25.5%: Here's is How to Trade
The average of price targets set by Wall Street analysts indicates a potential upside of 25.5% in Pediatrix Medical Group (MD). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Neutral
Zacks Investment Research
1 month ago
MD or HQY: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Medical Services sector might want to consider either Pediatrix Medical Group (MD) or HealthEquity (HQY). But which of these two stocks is more attractive to value investors?
Positive
Zacks Investment Research
1 month ago
MD Gains 11% Since Q4 Earnings Release, Unveils '25 View
Pediatrix Medical's fourth-quarter results reflect a declining overall expense level. It estimates 2025 net income to lie within $98.3-$112.9 million.
Charts implemented using Lightweight Charts™